#78 – New Therapies in HIV: The Long Road to Long-acting Antiretrovirals - Are We There Yet?
Breakpoints
00:00
Cabotage Vereal Pivrein: A New Drug for HIV Treatment
The most recent study that was presented at CROI was taking people on the most commonly used outpatient therapy for HIV, which is Bctegravir FDC TAF. The one-year results show non-inferiority of making the switch to cobbotegraviral pivoring. There's a small risk of virologic failure with resistance, and that was observed in three of the participants - just under 1%.
Transcript
Play full episode
